Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Significance of EGFR Expression in Circulating Tumor Cells.

Advances in experimental medicine and biology - 1 Jan 2017

Serrano María José, Alvarez-Cubero María Jesús, De Miguel Pérez Diego, Rodríguez-Martínez Alba, Gonzalez-Herrera Lucas, Robles-Fernandez Inmaculada, Hernandez José Exposito, Puche Jose Luis García, Lorente José Antonio

Abstract excerpt

This chapter focuses on a deep description of the epidermal growth factor receptor (EGFR) expression in circulating tumor cells (CTCs) and its main role in cancer progression, genetic changes related to metastasis , and resistance to treatment. The aberrant behavior of cancer cells is caused by genetic mutations and altered patterns of gene expression. These changes can be responsible for an increase in cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ErbB Receptors
Share to EGFR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasm Proteins

Share to Neoplasms

Share to Neoplastic Cells, Circulating

Source

Identifiers

PMID: 28560681
DOI: 10.1007/978-3-319-55947-6_16

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Significance of EGFR Expression in Circulating Tumor Cells.PMID 28560681Read ↗

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.Semantic proximity Read ↗

New Directions for Advanced Targeting Strategies of EGFR Signaling in CancerSemantic proximity Read ↗

EGFR mutations and abnormal trafficking in cancers.Semantic proximity Read ↗

Epidermal growth factor receptor: Role in human cancerSemantic proximity Read ↗

EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials.Semantic proximity Read ↗

Mutations and response to epidermal growth factor receptor inhibitors.Semantic proximity Read ↗

Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locationsSemantic proximity Read ↗

Circulating Tumor Cells: A Review of Non–EpCAM-Based Approaches for Cell Enrichment and IsolationSemantic proximity Read ↗

Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical RelevanceSemantic proximity Read ↗

Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis.Semantic proximity Read ↗

The EGFR family and its ligands in human cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.